According to the GuruFocus Value Screen for finding companies with Historical Low Price/Sales Ratios, there are currently 23 U. S. companies featured, including many familiar brand names. Here are three popular brand companies and a gold producer with historical low price/sales ratios, along with billionaire trading details as of the second quarter of 2013.
Weight Watchers International Inc. (WTW)
Predictability: 4 Stars
The current share price is around $37.74, which is 6.1% above its 52-week high. The P/S ratio is 1.19; its 10-year P/S low is 0.93. The Yield is 1.85%.
Down 28% over 12 months, Weight Watchers International Inc. has a market cap of $2.12 billion.
Weight Watchers International Inc. is a provider of weight management services, operating globally through a network of company-owned and franchise operations.
Guru Action: As of June 30, 2012, the top Guru stakeholder is Third Avenue Management with 0.64% of shares outstanding or 360,000 shares.
10 Best Low Price Stocks To Invest In 2015: Weyerhaeuser Company(WY)
Weyerhaeuser Company, a forest products company, grows and harvests trees, builds homes, and manufactures forest products worldwide. It grows and harvests trees for use as lumber, other wood and building products, and pulp and paper. The company manages 6.4 million acres of private commercial forestland; and has long-term licenses on 13.9 million acres of forestland. It also offers timber; minerals, such as rock, sand, and gravel, as well as oil and gas to construction and energy markets; logs; timberland tracts; and seed and seedlings, poles, plywood, and hardwood lumber products. In addition, the company provides structural lumber products for structural framing; engineered lumber products for floor and roof joists, and headers and beams; structural panels for structural sheathing, subflooring, and stair treading for wood products dealers, do-it-yourself retailers, builders, and industrial users. Further, it offers building products comprising cedar, decking, siding, ins ulation, rebar, and engineered lumber connectors. Additionally, the company offers fluff pulp for use in sanitary disposable products; papergrade pulp for printing and writing papers, and tissues; specialty chemical cellulose pulp for use in textiles, absorbent products, specialty packaging, and high-bulking fibers; liquid packaging board converted into containers; and slush and wet lap pulp for manufacturing paper products. It also constructs single-family houses, as well as develops residential lots and land for construction and sale; and master-planned communities with mixed-use property. The company sells its cellulose fibers products through direct sales network, and liquid packaging products directly to carton and food product packaging converters; and wood products through sales organizations and distribution facilities. Weyerhaeuser Company has been elected to be taxed as a real estate investment trust. The company was founded in 1900 and is headquartered in Federal Way, Washington.
Advisors' Opinion:- [By Dan Caplinger]
Weyerhaeuser (NYSE: WY ) will release its quarterly report on Friday, and given the recent strength in the housing market, investors are hoping that the provider of forest products will benefit from greater demand for construction materials for the homebuilding market. Yet even though Weyerhaeuser earnings growth looks almost assured, the stock hasn't reacted as favorably as shareholders would have hoped.
- [By Holly LaFon]
Pimco managing director Mark Kiesel mentions Whirlpool (WHR), Weyerhaeuser (WY), USG (USG), Toll Brothers (TOLL) and KB Home (KBH) as good plays on housing:�
10 Best Low Price Stocks To Invest In 2015: Ifg Group Ord Eur 0.12(IFP.L)
IFG Group plc, together with its subsidiaries, provides financial services primarily in Ireland, the United Kingdom, Isle of Man, Jersey, and Cyprus. It offers pensions administration services; independent financial advisory services to individuals, companies, charities, and other trusts; trust and corporate, and fund administration services; and administration and advisory, as well as personal financial and retirement planning services. The company is based in Dublin, Ireland.
Top 5 Penny Companies For 2014: PulteGroup Inc. (PHA)
PulteGroup, Inc., through its subsidiaries, engages in homebuilding and financial services businesses primarily in the United States. The company�s homebuilding business includes the acquisition and development of land primarily for residential purposes within the United States; and the construction of housing on such lands. It offers various home designs, including single-family detached, townhouses, condominiums, and duplexes under the Pulte Homes, Del Webb, and Centex brand names. As of December 31, 2011, its homebuilding operations offered homes for sale in approximately 700 communities. The company�s financial services business consists of mortgage banking and title operations. It arranges financing through the origination of mortgage loans for its homebuyers; sells such loans and related servicing rights; and provides title insurance policies as an agent, and examination and closing services to its home buyers. The company was formerly known as Pulte Homes, Inc. an d changed its name to PulteGroup, Inc. in March 2010. PulteGroup, Inc. was founded in 1956 and is headquartered in Bloomfield Hills, Michigan.
Advisors' Opinion:- [By DailyFinance Staff]
LM Otero, AP The housing market has been leading the economic recovery, but have housing stocks hit the ceiling? They're jumping today after a very bullish report on housing starts: New construction projects last month topped the 1 million annual rate for the time since before the financial crisis began in 2008. That's lifted shares of leading homebuilders by two to four percent today, adding to the huge gains over the past year. KB Homes (KBH), Pulte (PHA) and Hovnanian (HOV) have all doubled in price over the past year. Lennar (LEN) is up 44 percent, D.R. Horton (DHI) is up 47 percent and Toll Brothers (TOL) 33 percent. Those gains have prompted several other builders to go public this year. Taylor Morrison Home (TMHC), Tri Pointe, and William Lyon Home have all moved higher since their IPOs. And even though there's plenty of optimism that housing will continue to lead the broader economic recovery, there's some concern that these stocks may slow down. Homebuilder stocks can no longer be considered cheap. So some analysts see alternate routes for investors looking to play the housing boom. One way is through home-improvement retailers, which benefit from sales of both new and existing homes. Other plays include lumber, furniture and appliance companies. It's also worth noting that today's report on home construction showed that starts of single-family homes actually declined in March. It was the more volatile multi-family sector that led the advance. But there may be some stock market opportunities in REITs – real estate investment trusts – which focus on apartments. Among the biggest ones are Post Properties, Essex Property Trust and Associated Estates. They make money from collecting monthly rents. And these stocks generally trade below the value of the properties they own. Even some builders known for single-family homes are moving into the multi-family segment. Lennar announced in January that it plans to enter the apartment rental mar
10 Best Low Price Stocks To Invest In 2015: Endeavour Silver Corporation(EXK)
Endeavour Silver Corp., a mid-cap silver mining company, focuses on the growth of its silver production, reserves, and resources in Mexico and Chile. It principally holds interests in two producing silver mines in Mexico, including the Guanacevi mine, located in Durango State; and the Guanajuato mine located in Guanajuato State. Endeavour Silver Corp. was formerly known as Endeavour Gold Corp. and changed its name on September 14, 2004. The company was founded in 1981 and is headquartered in Vancouver, Canada.
Advisors' Opinion:- [By Rich Duprey]
Yet silver miners are producing record amounts of the metal. Coeur Mining (NYSE: CDE ) said that silver production jumped 21% in the second quarter�to 4.6 million ounces, with full-year production still anticipated to hit 18 million-19.5 million ounces, while Endeavor Silver (NYSE: EXK ) hit new records as production surged 48% to 1.5 million ounces.
- [By Selena Maranjian]
Endeavor Silver (NYSE: EXK ) sank 58%. It's focused on silver mines in Mexico and also mines gold. Last month, due to one of its three mines outperforming, management raised silver-production projections by 20%, representing a 34% increase over 2012 levels. Gold-production forecasts were hiked 48%. Not all mines are performing well, though, and the price of silver has fallen, so the company has been cutting costs, in part via layoffs.
- [By Dan Caplinger]
Next Monday, Endeavour Silver (NYSE: EXK ) will release its latest quarterly results. The key to making smart investment decisions on stocks reporting earnings is to anticipate how they'll do before they announce results, leaving you fully prepared to respond quickly to whatever inevitable surprises arise. That way, you'll be less likely to make an uninformed knee-jerk reaction to news that turns out to be exactly the wrong move.
- [By The Investment Doctor]
In this article I'll have a look at Endeavour Silver's (EXK) second quarter results. In an earlier article I was afraid the company would be free cash flow negative at a silver price of $20/oz. I'll now have a look at the financial results to see if the company indeed had a net cash outflow, and what consequence this had on its balance sheet.
10 Best Low Price Stocks To Invest In 2015: MedCath Corporation(MDTH)
MedCath Corporation, together with its subsidiaries, engages in the ownership and operation of hospitals in partnership with physicians in the United States. The company focuses primarily on providing acuity services, including the diagnosis and treatment of cardiovascular disease. As of November 11, 2011, MedCath Corporation owned and operated 2 hospitals with a total of approximately 159 licensed beds, located in California and Texas. The company was founded in 1996 and is headquartered in Charlotte, North Carolina.
10 Best Low Price Stocks To Invest In 2015: Reed Resources Ltd(RDR.AX)
Reed Resources Ltd engages in the mining and exploration of mineral properties in Western Australia. The company explores for steel, lithium, gold, nickel, vanadium, and iron ore deposits. Its principal projects include, the Meekatharra gold project located in the Murchison region; the Mount Marion lithium project located to the south of Kalgoorlie in the Goldfields region; the Comet Vale gold project located to the north of Kalgoorlie; the Mount Finnerty project, an iron ore and nickel project situated to the east of Koolyanobbing; and the Barrambie Vanadium project located in the mid west region of Western Australia. The company also owns interests in the Bell Rock Range nickel project located in the western part of the Proterozoic Musgrave Block in central Australia. Reed Resources Ltd is based in West Perth, Australia.
10 Best Low Price Stocks To Invest In 2015: Merrimack Pharmaceuticals Inc (MACK)
Merrimack Pharmaceuticals, Inc., incorporated in 1993, is a biopharmaceutical company discovering, developing and preparing to commercialize medicines paired with companion diagnostics for the treatment of serious diseases, with an initial focus on cancer. The Company�� product candidates include MM-398, MM-121, MM-111, MM-302 and MM-151. As of June 31, 2011, the Company owned approximately 74% interest of Silver Creek.
The Company�� Network biology is an interdisciplinary approach to drug discovery and development that enables the Company to build functional and predictive computational models of biological systems based on quantitative, kinetic, multiplexed biological data. The Company provides its scientists with insights into how the complex molecular interactions that occur within cell signaling pathways, or networks, regulate cell decisions and how dysfunction within these networks leads to disease. The Company applies network biology throughout the research and development process, including for target identification, lead compound design and optimization, diagnostic discovery, in vitro and in vivo predictive development and the design of clinical trial protocols.
MM-398
MM-398 is a stable nanotherapeutic encapsulation, or enclosed sphere carrying an active drug, of the marketed chemotherapy drug irinotecan. MM-398 achieved its primary efficacy endpoints in Phase 2 clinical trials in pancreatic and gastric cancer. In an open label, single arm Phase 2 clinical trial of MM-398 as a monotherapy in 40 metastatic pancreatic cancer patients who had previously failed treatment with gemcitabine, patients treated with MM-398 achieved median overall survival of 22.4 weeks. Additionally, 20% of the patients in this Phase 2 trial survived for more than one year, and the Company observed a disease control rate, meaning patients exhibited stable disease or partial or complete response to treatment, of 47.5% at six weeks.
The Company focuses on initiati! ng a Phase 3 clinical trial of MM-398 for the treatment of patients with metastatic pancreatic cancer who have previously failed treatment with gemcitabine. The trial is expected to enroll approximately 250 patients and is designed to compare the efficacy of MM-398 as a monotherapy against the combination of the chemotherapy drugs fluorouracil, or 5-FU, and leucovorin. There are multiple ongoing Phase 1 and Phase 2 clinical trials of MM-398. In July 2011, the United States Food and Drug Administration (FDA) granted MM-398 orphan drug designation for the treatment of pancreatic cancer.
MM-121
MM-121 is a fully human monoclonal antibody that targets ErbB3, a cell surface receptor, or protein attached to the cell membrane that mediates communication inside and outside the cell, that the Company�� network biology approach identified as a target in a range of cancers. A monoclonal antibody is a type of protein normally produced by cells of the immune system that binds to just one epitope, or chemical structure, on a protein or other structure. MM-121 is designed to inhibit cancer growth directly, restore sensitivity to drugs to which a tumor has become resistant and delay the development of resistance of a tumor to other agents. In collaboration with Sanofi, the Company focuses on testing MM-121 in combination with both chemotherapies and other targeted agents across a range of spectrum of solid tumors, including lung, breast and ovarian cancers. The Company partnered MM-121 with Sanofi after it initiated Phase 1 clinical development of the product candidate.
MM-111
MM-111 is a bispecific antibody designed to target cancer cells that are characterized by overexpression of the ErbB2 cell surface receptor, also referred to as HER2. A bispecific antibody is a type of antibody that is able to bind simultaneously to two distinct proteins or epitopes. The Company�� network biology approach identified that ligand-induced signaling through the complex of ErbB2 ! (HER2) an! d ErbB3 is a promoter of tumor growth and survival than previously appreciated.
MM-302
MM-302 is a nanotherapeutic encapsulation of doxorubicin with attached antibodies that are designed to target MM-302 to cells that over express the ErbB2 (HER2) receptor. The Company is conducting a Phase 1 clinical trial of MM-302 in patients with advanced ErbB2 (HER2) positive breast cancer.
MM-151
MM-151 is an oligoclonal therapeutic consisting of a mixture of three fully human monoclonal antibodies designed to bind to non-overlapping epitopes of the epidermal growth factor receptor (EGFR). EGFR is also known as ErbB1. An oligoclonal therapeutic is a mixture of two or more distinct monoclonal antibodies. The Company has designed MM-151 to block signal amplification that occurs within the ErbB cell signaling network. The Company has submitted an investigational new drug application (IND), to the FDA for MM-151 in July 2011.
Advisors' Opinion:- [By Roberto Pedone]
One under-$10 biopharmaceuticals player that's just starting to trigger a breakout trade is Merrimack Pharmaceuticals (MACK), which focuses on discovering, developing and preparing to commercialize medicines paired with companion diagnostics for the treatment of serious diseases, with an initial focus on cancer. This stock has been hit hard by the bears so far in 2013, with shares off by 38%.
If you take a look at the chart for Merrimack Pharmaceuticals, you'll notice that this stock has been downtrending badly for the last two months, with shares plunging from its high of 7.09 to its recent low of $3.26 a share. During that move, shares of MACK have been consistently making lower highs and lower lows, which is bearish technical price action. That said, shares of MACK have just formed a double bottom chart pattern at $3.26 to $3.32 a share and it's now starting to break out above some near-term overhead resistance at $3.64 a share. This move could be signaling a trend change for MACK as the stock starts to move higher off oversold conditions.
Traders should now look for long-biased trades in MACK if it manages to break out above some near-term overhead resistance at $3.64 a share with high volume. Look for a sustained move or close above that level with volume that hits near or above its three-month average action of 1.87 million shares. If that breakout triggers soon, then MACK will set up to re-test or possibly take out its next major overhead resistance level at its 50-day moving average of $4.75 a share. Any high-volume move above that level and above more resistance at $5.06 will then give MACK a chance to tag its 200-day moving average at $5.71 a share.
Traders can look to buy MACK off weakness to anticipate that breakout and simply use a stop that sits right below some key near-term support levels at $3.32 or at $3.26 a share. One can also buy MACK off strength once it clears $3.64 a share with volume and then simply use a stop tha
- [By Keith Speights]
Not so merry
Merrimack Pharmaceuticals (NASDAQ: MACK ) shareholders have had reason to party since early May, with the stock surging more than 60%. The merriment came to a stop this week, though, as shares tanked by 27%. - [By Eric Volkman]
Merrimack Pharmaceuticals (NASDAQ: MACK ) is gearing up for a double dose of fund-raising. The company announced that it will concurrently float both a common stock and a convertible notes issue in a public offering. In the former, Merrimack will offer $50 million worth of shares, while the latter will take the form of $75 million in senior notes maturing in 2020. Additionally, the company expects that it will grant its underwriters a 30-day purchase option for up to an additional $7.5 million worth of common shares and $11.25 million of the convertible notes.
- [By Monica Gerson]
Merrimack Pharmaceuticals (NASDAQ: MACK) dipped 15.38% to $2.86 after the company reported that Phase 2 study Of MM-121 missed primary endpoint.
IAC/InterActiveCorp (NASDAQ: IACI) shares fell 14.51% to $49.50 in the pre-market trading after the company reported downbeat Q3 revenue.
10 Best Low Price Stocks To Invest In 2015: Seven Group Holdings Limited(SVW.AX)
Seven Group Holdings Limited, through its subsidiaries, engages in the media and broadcasting, newspaper and magazine publishing, heavy equipment sales and service, equipment hire, and online businesses in Australia and China. The company operates as a Caterpillar dealer, which provides heavy equipment sales and support services to customers in Western Australia, New South Wales, and the Australian Capital Territory. It is also involved in the manufacture, assembly, sale, and support of lighting, power generation, and dewatering equipment; and rental of equipment, as well as distribution of Perkins engines. In addition, it engages in the operations of broadband, telephony, and other listed investments and properties. The company was formerly known as Seven Network Limited and changed its name to Seven Group Holdings Limited in April 2010, as a result of merger with WesTrac Holdings Pty Limited. Seven Group Holdings Limited is headquartered in Pyrmont, Australia.
10 Best Low Price Stocks To Invest In 2015: First Trust NASDAQ Clean Edge Smart Grid Infrastructure Index Fund (GRID)
NA
Advisors' Opinion:- [By Selena Maranjian]
Exchange-traded funds offer a convenient way to invest in sectors or niches that interest you. If you'd like to add some smart grid stocks to your portfolio, but don't have the time or expertise to hand-pick a few, the First Trust NASDAQ Clean Edge Smart Grid Infrastructure ETF (NASDAQ: GRID ) could save you a lot of trouble. Instead of trying to figure out which companies will perform best, you can use this ETF to invest in lots of smart grid stocks simultaneously.
The basics
ETFs often sport lower expense ratios than their mutual fund cousins. The First Trust ETF's expense ratio -- its annual fee -- is 0.70%, which is a bit more than many ETFs, but still considerably lower than a typical stock mutual fund. The fund is fairly small, too, so if you're thinking of buying, beware of possibly large spreads between its bid and ask prices. Consider using a limit order if you want to buy in.
10 Best Low Price Stocks To Invest In 2015: Vvc Exploration Corporation (VVC.V)
VVC Exploration Corporation engages in the exploration and development of mineral properties in Canada and Mexico. It primarily explores for gold, silver, lead, and zinc ores, as well as for precious and base metals. The company was incorporated in 1983 and is based in Toronto, Canada.
No comments:
Post a Comment